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Introduction—Appendicitis is the most common emergency condition in children. Historically,
a 3-drug regimen consisting of ampicillin, gentamicin, and clindamycin (AGC) has been used
postoperatively for perforated appendicitis. A retrospective review at our institution has found
single day dosing of ceftriaxone and metronidazole (CM) to be a more simple and cost-effective
antibiotic strategy. Therefore, we performed a prospective, randomized trial to compare efficacy
and cost-effectiveness of these 2 regimens.
Methods—After internal review board approval (IRB no. 04 12-149), children found to have
perforated appendicitis at appendectomy were randomized to either once daily dosing of CM (2
total doses per day) or standard dosing of AGC (11 total doses per day). Perforation was defined
as an identifiable hole in the appendix. The operative approach (laparoscopic), length of antibiotic
use, and criteria for discharge were standardized for the groups. Based on our retrospective
analysis using length of postoperative hospitalization as a primary end point, a sample size of 100
patients was calculated for an α of .5 and a power of 0.82.
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Results—One hundred patients underwent laparoscopic appendectomy for perforated
appendicitis. On presentation, there were no differences in sex distribution, days of symptoms,
temperature, or leukocyte count. There was no difference in abscess rate or wound infections
between groups. The CM group resulted in significantly less antibiotic charges then the AGC
group.
Conclusions—Once daily dosing with the 2-drug regimen (CM) offers a more efficient, costeffective antibiotic management in children with perforated appendicitis without compromising
infection control when compared to a traditional 3-drug regimen.
Keywords
Antibiotic regimen; Perforated appendicitis; Children
Triple antibiotic therapy providing broad-spectrum coverage of gram-positive, gramnegative, and anaerobic bacteria has been the standard treatment of perforated appendicitis
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in children. This therapy usually uses ampicillin, gentamicin, and clindamycin. These
medications are individually inexpensive; however, each is administered multiple times per
day creating a complex dosing schedule. Gentamicin is an aminoglycoside with known renal
and ototoxic side effects that requires the measurement of serum levels. Although this
regimen has been safe and reliably effective, contemporary antibiotics allows a large
selection of drugs that do not require laboratory monitoring.
We have retrospectively showed that a 2-drug regimen consisting of ceftriaxone (Rocephin,
Roche Pharmaceuticals, Nutley, NJ) and metronidazole (Flagyl, Pharmacia Corporation,
Chicago, Ill) can be used in a single daily dosing regimen for perforated appendicitis with
some clinical benefits including cost [1]. In this study, we used once-a-day dosing for both
medications.
To verify the findings of our retrospective review, we conducted a definitive, prospective,
randomized trial comparing single daily dosing with ceftriaxone and metronidazole (CM) to
a standard triple antibiotic regimen of ampicillin, gentamicin, and clindamycin (AGC).

1. Methods
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Approval was obtained from the Children's Mercy Hospital internal review board (IRB)
(IRB no. 04 12-149) before enrolling patients in this study. Patients were subsequently
enrolled only after obtaining consent from the patient's legal guardian. The consent forms
and consent process were carefully evaluated by the IRB on a continual basis.
1.1. Participants
The study population consisted of children with perforated appendicitis. Inclusion criteria
required the presence of perforation. Perforation was defined as an identifiable hole in the
appendix, which was not iatrogenic. In cases where this was not obvious at laparoscopic
appendectomy, the extracted specimen was carefully inspected for the presence of hole.
Exclusion criteria included patients with a documented allergy to any of the medications in
the trial. Those with an abscess identified by computed tomographic (CT) scan before
surgery were not included in the study. These patients were excluded from the study
because, at the time of this study, the standard management in our institution for children
with perforated appendicitis with abscess was abscess drainage followed by interval
laparoscopic appendectomy.
1.2. Interventions
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After determination of perforation, patients were randomized to receive either ceftriaxone
and metronidazole or triple antibiotic therapy as the postoperative antibiotic regimen. Triple
antibiotic therapy consisted of ampicillin, gentamicin, and clindamycin. Resuscitation fluid
in all cases was normal saline because of the FDA concerns about the use of lactated
Ringers solution in combination with ceftriaxone.
1.3. Sample size
The power calculation was based on the length of hospitalization for patients treated with
the 2 different antibiotic regimens in our previously mentioned retrospective study. A
sample size of 50 patients in each arm with α of .05 provided a power of 0.82.
1.4. Assignment
An individual unit of randomization was used in an unblocked, nonstratified sequence.
Perforation was defined by the surgeon at the time of the operation after which the family
J Pediatr Surg. Author manuscript; available in PMC 2011 April 26.
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was approached for consent. The randomization sequence was accessed to identify the next
allotment after the consent was signed.
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1.5. Protocol
Appendectomies were performed by one of the 7 institutional staff surgeons as dictated by
the call schedule. Abdominal CT scans were obtained as clinically necessary to make the
diagnosis of appendicitis. All of the appendectomies were initiated laparoscopically.
Nasogastric tubes were not used after the operation [2].
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Postoperative orders were controlled via a standard electronic order set for all operations.
All patients received a 5-day course of intravenous antibiotics. A white blood cell count was
drawn on postoperative day 5 in all patients. If this was normal, the patient was not febrile
and was tolerating a regular diet, they were discharged home without oral antibiotics. If
leukocytosis was found, the patient received 2 additional days of antibiotics, and the white
blood cell count evaluation is repeated. If the white blood cell count remained elevated, they
received another 3 days of antibiotics, and a CT scan was obtained to evaluate for the
presence of an abscess. In addition, CT scans were obtained if the patient's clinical condition
suggested an abdominal abscess at any time after 7 days. All patients who developed
postoperative abscesses were treated with intravenous antibiotics consisting of the CM
regimen that allowed for more efficient home administration. Drainage and length of
treatment of abscesses were dictated by the individual treating surgeons.
The group allotted to the 2-drug regimen received once-a-day dosing of ceftriaxone (50 mg/
kg) and metronidazole (30 mg/kg). The group randomized to the 3-drug regimen received
ampicillin (50 mg/kg per dose) every 6 hours, gentamicin (2.5 mg/kg per dose) every 8
hours, and clindamycin (10 mg/kg per dose) every 6 hours. In this group, serum gentamicin
peak and trough levels were drawn after the third dose.
1.6. Data collection
All data were collected prospectively. At the time of presentation, the patient's age, weight,
sex, days of symptoms, maximum temperature, and white blood cell count were collected.
Operative variables collected included the operative approach, operative, and all
intraoperative complications including conversion to the open approach.
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The outcome variables included maximum daily temperatures for each of the first 5
postoperative days, time to initial oral intake, time to regular diet, length of hospitalization,
length of antibiotic therapy, total medication charges, antibiotic charges, abscess rate, wound
infection rate, and any abnormal findings during the postoperative or follow-up visits.
1.7. Statistical analysis
Continuous variables were compared using an independent sample, 2-tailed Student's t test.
Discrete variables were analyzed with Fisher's Exact test with Yates correction where
appropriate. Significance was defined as P value ≤ .05. Descriptive statistics were calculated
as mean ± SD.

2. Results
From April 2005 to November 2006, 100 patients were enrolled in the study. Two patients
were dropped from the study. One was because of surgical failure because of a retained
fecalith not removed at the initial operation. The other was because of an urgent family need
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to transfer the patient to a facility closer to their home before the postoperative course was
complete.
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2.1. Demographics
The mean maximum temperature was 37.8°C in both groups. The mean duration of
symptoms at presentation was 3.2 ± 2.2 days in the CM group compared to 3.0 ± 1.9 days in
the AGC group (P = .70). The sex distribution was 57% male in the CM group compared to
65% in the AGC group (P = .60). Mean age in years was 9.9 ± 4.0 in the CM group
compared to 7.3 ± 4.2 in the AGC group (P = .02). Mean weight in kilograms was 39.0 ±
22.2 in the CM group compared to 29.9 ± 20.1 in the AGC group (P = .04). Thus, the CM
patient's were slightly older and, subsequently, heavier because of a few outliers, which did
reach statistical significance.
2.2. Operation
There was no difference in operating time between the groups (Table 1). One patient in the
CM group had an ileal injury with circumferential deserosalization, which was managed
conservatively. This patient recovered well from the operation but subsequently was
readmitted with partial bowel obstruction also managed conservatively. A single patient
required conversion from the laparoscopic approach to an open procedure, and he was in the
AGC group.
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2.3. Outcome
No difference existed in time to full oral intake, the length of the postoperative
hospitalization, or abscess rate between the 2 groups (Table 1). There was no difference in
the fever curves for the first 5 postoperative days between the 2 groups (Fig. 1). One patient
in the AGC group developed a wound infection compared to no wound infections in the CM
group. Significantly higher antibiotic charges were incurred by the AGC group (Table 2).
In patients who developed an abscess, those in the CM group received an additional 11.7 ±
7.0 days of intravenous antibiotics and 2 patients received an additional 10 days of oral
antibiotics without additional intravenous therapy. Those abscess patients from the AGC
group received an additional 14.1 ± 4.3 days of intravenous antibiotics, 1 patient received
another 10 days of oral antibiotics, and 2 patients took oral antibiotics for 7 days. The
difference in days of additional intravenous therapy was not significant (P = .4).
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In the AGC group, no clinically useful gentamicin levels were available in 8 patients
because of error or inadequate specimen collection. The recorded gentamicin serum levels
were persistently below the therapeutic window in an additional 10 patients. Therefore, only
31 patients (63%) receiving gentamicin ever achieved therapeutic level. Of these, only 17
patients (35%) were found to have a therapeutic level from the outset, whereas the
remainder spent a portion of their hospital stay below the therapeutic level. Regarding serum
analysis, a mean of 3 draws per patient was required for monitoring. This resulted in a mean
charge of $482 per patient for gentamicin tests.

3. Discussion
Triple antibiotic therapy for perforated appendicitis is still common practice in pediatric
surgery despite several reports of simpler antibiotic regimens [3–5]. Monotherapy with
newer broad-spectrum agents such as piperacillin/tazobactam for intraabdominal infections
has recently been shown to be equally efficacious as traditional triple therapy [3,4].
Similarly, cefotaxime, a cephalosporin with a similar profile to ceftriaxone, has been shown
to be equal to the aforementioned monotherapy schedule of piperacillin/tazobactam in
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children with complicated perforated appendicitis when combined with metronidazole [5].
Monotherapy seems more advantageous than a dual regimen. However, the expenses of
most of the newer broad-spectrum medications are increased by 1 or 2 levels of magnitude
over the medications in this trial. Perhaps overlooked and most important, independent of
health care cost, the charges to the patient are inseparably linked to dosing schedule. This
impact of decreased dosing on antibiotic expenses has been emphasized by several authors
[6–11]. In particular, a dramatic decrease in expense has been shown with once daily dosing
of ceftriaxone compared to broad-spectrum monotherapeutic agents in the penicillin and
cephalosporin families in several studies [6,9–16].
It has been shown that ceftriaxone and metronidazole provide comprehensive coverage for
most enteric organisms in prophylactic studies as well as traumatic and surgical
contamination studies [6,17–23]. However, the novel contribution of the regimen used in our
study is the institution of once-a-day dosing of metronidazole. Previously, once daily dosing
of ceftriaxone and metronidazole has been shown to be superior to ampicillin, netilmicin,
and metronidazole for the treatment of bacterial peritonitis in a prospective, controlled
clinical trial in adults [21].
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On the basis of this evidence, we began using a once-a-day dosing schedule of ceftriaxone
and metronidazole nearly 4 years ago. We retrospectively reviewed our experience of once
daily dosing of metronidazole and found it to be more cost-effective than triple antibiotic
therapy [1]. In addition, we identified a shorter length of hospitalization and more rapid
defervescence with the CM regimen. However, several flaws mandated this study to be
verified by a prospective, randomized trial. First, that study was retrospective with most
comparison group not occurring concurrently, thus creating a historical comparison. In
addition, during the time frame of the current study, there has been a general trend to get
patients home sooner, which may have contributed to a shorter length of hospitalization that
was not found in our prospective trial. Second, far more operations in the retrospective CM
group were done laparoscopically. This is the likely reason we identified different
temperature curves in the retrospective series but not in this prospective trial.
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Regarding charges, we used calculated charges in the retrospective comparison to
compensate for the historical, nonconcurrent comparison of the 2 groups. We found the CM
regimen to be significantly more cost-effective. In this prospective trial, we used actual
billing charges to the patient. These billing numbers confirm the retrospective experience
that charges for intravenous antibiotics during the hospital stay were significantly less for
the CM regimen. The additional antibiotic charges for the patients who developed an
abscess were, on average, $8000 less in the CM group. This did not reach significance
because of the small number of patients with an abscess and the wide variation of charges
per individual case as reflected by the large SD. There may be a suggestion from these data
that abscesses were more virulent in the AGC group because both groups were treated with
the same antibiotics. However, the mean time of additional intravenous antibiotics for
abscess treatment was only 3 days less in the CM group, which did not reach significance.
In this study, we had a slightly older and heavier patient population in the CM group. This is
an unusual but possible event in a prospective randomized trial even when the
randomization process was strictly followed with no mistakes in the order. This difference in
weight (39 vs 29 kg) or age (9 vs 7 years), was statistically significant, but only a few very
heavy teenagers in the CM group account for this difference. This patient base has a
theoretically increased risk of postoperative abscess because of obesity. Indeed, 4 of the 6
patients in the CM group more than 70 kg did develop an abscess. In spite of this finding,
the overall data were in favor of the CM group.
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It is important to understand the difficulty establishing therapeutic levels of gentamicin. In
this study, we had a prospective protocol in place, a standard computerized order set, a
surgical floor with nurses experienced in managing these patients and medications, and a
research coordinator that followed the database daily. Despite these strengths, only one third
of the patients had therapeutic levels of gentamicin throughout the antibiotic course. From
our experience, we can only assume that most patients receiving gentamicin treatment as
part of the antibiotic regimen for perforated appendicitis around the world are not uniformly
receiving adequate therapy. This finding in our study may also be interpreted as a suggestion
that gram-negative coverage is not the critical component of this regimen, given infectious
complications were not higher in this group despite the inadequate gentamicin levels.
Any comparative antibiotic trial should not only offer its current findings but at least
contemplate the possibility of microbial resistance changing the efficacy of the regimen with
time. There are no published data regarding the propensity of microbial resistance between
the 2 regimens compared in this trial. However, neither combination holds a great deal of
double coverage for individual strains. Therefore, the expected resistance rates should not
differ discernibly.
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We conclude that once daily dosing of both ceftriaxone and metronidazole is equal to
standard triple antibiotic therapy for infection control in the treatment of perforated
appendicitis in children. However, the 2-drug regimen is more cost-effective and easier for
patients and caregivers. Until a more superior regimen is identified, we recommend that
single day dosing of ceftriaxone and metronidazole be used in all patients with perforated
appendicitis.
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Fig. 1.

Maximum recorded temperature for the 2 groups on admission and each of the first 5
postoperative days.
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Table 1

Clinical outcomes
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CM (n = 49)
Mean operating time (min-s)

AGC (n = 49)

40:56 ± 17:33

Mean time to regular diet (h-min)

P

48:28 ± 25:29

.09

75:56 ± 47:40

78:03 ± 39:27

.82

Mean length of stay after operation (h-min)

154:50 ± 68:56

151:59 ± 81.01

.85

Postoperative abscess (%)

20

16

.60

Wound infection (%)

0

2

.99
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Table 2

Financial comparison
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CM
(n = 49)

AGC
(n = 49)

Inhospital intravenous antibiotic charges ($)

1413 ± 782

1940 ± 633

Abscess intravenous antibiotic charges ($)

9224 ± 8424

17,308 ± 11,697

Mean % of medication charge for antibiotics

4.5

6.1

P
<.001
.10
<.001
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